Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001553487 | SCV001774367 | pathogenic | not provided | 2019-08-20 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016) |
Labcorp Genetics |
RCV001553487 | SCV002128243 | pathogenic | not provided | 2023-08-31 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1192143). This sequence change creates a premature translational stop signal (p.Lys2695*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003451808 | SCV004182848 | pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003451808 | SCV005055741 | likely pathogenic | Retinitis pigmentosa 39 | 2024-01-13 | criteria provided, single submitter | clinical testing |